Resultados de la búsqueda 1571-1580 of 15635 for Crohns disease

  1. Ensayos clínicos - Neurología

    Rochester, Minn., Jacksonville, Fla. To further investigate biomarkers in CSF as possible predictors for mild cognitive impairment and dementia. A Study of ...

  2. Ensayos clínicos - Neurología

    We will identify innate immune cell populations that contribute to astrocyte reactivity and elucidate the mechanisms responsible for altering the ...

  3. Neurología - Ensayos clínicos

    Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

  4. Trastorno depresivo persistente - Síntomas y causas - Mayo Clinic

    In: Diagnostic and Statistical Manual of Mental Disorders DSM-5-TR. American ... Review of dysthymia and persistent depressive disorder: History, correlates, and ...

  5. Problemas hepáticos - Síntomas y causas - Mayo Clinic

    In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 11th ed. Elsevier; 2021. https://www.clinicalkey ...

  6. Cáncer de lengua - Síntomas y causas - Mayo Clinic

    Treatment of stage I and II (early) head and neck cancer: The oral cavity. https://www.uptodate.com/contents/search. Accessed Jan. 18, 2023. Flint PW, et al ...

  7. Difteria - Síntomas y causas - Mayo Clinic

    ... and-cold-products-kids. Accessed May 9, 2022. Vaccine (shot) for diphtheria. Centers for Disease Control and Prevention. https://www.cdc.gov/vaccines ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL). Jacksonville, Fla. The purpose of this study is to determine the safety and feasibility of ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer ...

  10. Hematología - Ensayos clínicos

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving acalabrutinib ...